DoD | GenomeWeb

DoD

The colon cancer test is now available through Tricare for 9.4 million active duty, reserve, and National Guard personnel, as well as veterans and their dependents.

Announced this month, the project brings together CPTAC, the VA, and DoD, and has as its initial goal the proteogenomic analysis of 8,000 lung cancer patients.

The Huntsville, Alabama-based genetic testing firm continues its relationship with the Combating Terrorism Technical Support Office.

IXpressGenes will study environmental DNA samples from extreme environments in order to find unique metabolic pathways that could yield new classes of antibiotics.

A GAO review finds no evidence of disparities in grant success rates by gender at agencies with sufficient data, but some agencies are not conducting required Title IX compliance reviews.

The US Centers for Disease Control and Prevention is investigating the handling of samples at four Department of Defense labs, the New York Times reports.

Procedures Faulted

Inadequate procedures led to the shipment of live anthrax to sites around the world, Pentagon report says.

The US Department of Defense plans to begin collecting data so that it can determine whether women face discrimination when seeking grants from the agency.

MRIGlobal will develop the whole-genome diagnostic system to identify a broad range of human pathogens with a focus on emerging pathogens.

NEW YORK (GenomeWeb) — BioMérieux yesterday reported approximately 4 percent organic revenue growth for the first nine months of 2014, driven by organic growth in all of its clinical application areas but particularly in molecular biology and immunoassays.

Pages

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.